Business of Cannabis Europe
Oxford Cannabinoid Technologies Publishes Phase I Clinical Trial Results for Lead Drug CandidateÂ
Oxford Cannabinoid Technologies Holdings plc (LSE: OCTP), the pharmaceutical company developing prescription cannabinoid medicines, is pleased to announce that dosing of